What is Anti-Mullerian Hormone (AMH)?
AMH is widely regarded as the most reliable indicator of ovarian reserve. AMH provides a comparison of an individual’s relative number of remaining eggs compared to others of her age. Studies indicate that AMH may be the best marker of reproductive outcome for patients undergoing assisted reproduction, and may also characterize conditions such as Polycystic ovarian syndrome (PCOS). AMH helps to indicate the duration of an remaining natural fertility and to predict the onset of menopause.
The expected number of normal chromosomes in human is 46 (23 pairs). In certain cases of infertility (premature ovarian insufficiency in females, and severe azoospermia in males), or in cases of recurrent miscarriage, there may be a variation in the number or structure of the chromosomes. Counting the number of chromosomes with the karyotype test can help explain the cause for some of these problems.
Sperm DNA fragmentation testing
While the semen analysis is the cornerstone of the male fertility evaluation, the ability to assess normal sperm function is limited. Sperm DNA fragmentation can identify when the probability for natural fertilization is low, and if intrauterine insemination (IUI) treatment is likely to be successful.
Some cases azoospermia or severe oligospermia (low sperm count) can be explained by genetic mutations on the Y chromosome, known as microdeletions. Detecting these mutations can potentially determine the best course of treatment.
genetic carrier screening
80% of children born with a genetic condition have no family history of that disease. CarrierMap is an expanded carrier screen that can help you plan for a healthy family. Over 300 genetic diseases can be screened, helping you determine your risk for passing these diseases to your child. (This test is not offered anymore)